AzTrials
AzTrials

Adhesive Small Bowel ObstructionNCT04318821

Effect of Laser Acupuncture on Adhesive Small Bowel Obstruction

A study testing Laser acupuncture in people with Adhesive Small Bowel Obstruction, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Adhesive small bowel obstruction (ASBO) is one of the most common complications and is a major cause of admission after intra-abdominal surgery. To date, the ideal management of ASBO remains controversial. Read more about this study

Who is it for?
Ages 20 to 80 years
Conditions the study is for
Adhesive Small Bowel Obstruction
What is being tested?
Laser acupuncture
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
30 participants
Where
1 siteTaiwan
Study dates
1 Mar 2020to 28 Feb 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged 20 to 80 years
  • Clinical symptoms and signs of mechanical obstruction

Who cannot join

  • Clear non-adhesive etiology of small bowel obstruction (e.g. tumor, hernia)
  • Emergency surgical intervention before being admitted to the hospital
  • Pregnancy
  • Local skin infection on the acupoints, and limb amputees.

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Kaohsiung Chang Gung Memorial Hospital

    Kaohsiung City, 833

Other trials in Taiwan

About this study

Official title: Effect of Laser Acupuncture on Adhesive Small Bowel Obstruction: a Prospective Double-blind Randomized Controlled Trial

Adhesive small bowel obstruction (ASBO) is one of the most common complications and is a major cause of admission after intra-abdominal surgery. To date, the ideal management of ASBO remains controversial. The aim of this protocol designed as a double-blind randomized controlled trial is to investigate the efficacy of laser acupuncture (LA) therapy in patients with ASBO.

Being tested
Laser acupuncture
Keywords
Adhesive small bowel obstruction, Laser acupuncture, Acupuncture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laser acupunctureProcedure or surgery

    Laser acupuncture is a non-invasive therapy that involves stimulation of traditional acupoints with low-intensity, non-thermal laser irradiation.

Study groups in NCT04318821
Study groupRoleWhat they receive
LA groupExperimentalThe subjects in the experimental group will receive 0.375 J of energy at each of the following acupoints: LI4 (Hegu, B3), PC6 (Neiguan, B3), ST25 (Tianshu, B3), ST36 (Zusanli, B2), CV4 (Guanyuan), CV12 (Zhongwan, B3).
Receives: Procedure: Laser acupuncture
Control groupSham comparatorThe subjects in the control group will receive sham LA treatment, without any laser output (no stimulation) at the same acupoints used in experimental group.
Receives: Procedure: Laser acupuncture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success rate of conservative treatment

    Defined as no need for long term nasogastric tube decompression and operative intervention.

    Measured: 2 week

Secondary outcomes (8)
  1. Time to oral intake

    Defined as participants can try intake due to symptoms improved including nausea, vomiting, distension and pain.

    Measured: 2 weeks

  2. Length of hospital stay

    Date from admission to discharge

    Measured: Through study completion, an average of 1 year

  3. Serum lipase

    Serum lipase

    Measured: Up to 2 weeks

  4. Serum amylase

    Serum amylase

    Measured: Up to 2 weeks

  5. Serum cortisol

    Serum cortisol

    Measured: Up to 2 weeks

  6. Serum motilin

    Serum motilin

    Measured: Up to 2 weeks

  7. Serum ghrelin

    Serum ghrelin

    Measured: Up to 2 weeks

  8. Serum intestinal fatty acid binding protein (I-FABP)

    Serum intestinal fatty acid binding protein (I-FABP)

    Measured: Up to 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Mar 2020
  2. Study start1 Mar 2020
  3. Primary completion1 Feb 2023
  4. Study completion28 Feb 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04318821
Sponsor's protocol ID
CMRPG8K0571
Status last verified
Mar 2023
First submitted
16 Mar 2020
Last updated
17 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Shih CH, Hsieh TM, Wu BY, Liu CT. Effect of laser acupuncture on adhesive small bowel obstruction: A prospective double-blind randomized controlled trial. Medicine (Baltimore). 2021 Mar 5;100(9):e25035. doi: 10.1097/MD.0000000000025035.

    PubMed 33655978

Questions about this trial

What is this clinical trial studying?

A study testing Laser acupuncture in people with Adhesive Small Bowel Obstruction, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success rate of conservative treatment (time frame: 2 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04318821, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in